Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis

Lysine specific demethylase 1 (LSD1; also known as KDM1A), is an epigenetic modulator that modifies the histone methylation status. KDM1A forms a part of protein complexes that regulate the expression of genes involved in the onset and progression of diseases such as cancer, central nervous system (...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Fernando Cavalcanti, Elena Gonzalez-Rey, Mario Delgado, Clara P. Falo, Leyre Mestre, Carmen Guaza, Francisco O’Valle, Michele M. P. Lufino, Jordi Xaus, Cristina Mascaró, Serena Lunardi, Natalia Sacilotto, Paola Dessanti, David Rotllant, Xavier Navarro, Mireia Herrando-Grabulosa, Carlos Buesa, Tamara Maes
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-07-01
Schriftenreihe:	Pharmaceutics
Schlagworte:	epigenetics KDM1A vafidemstat multiple sclerosis neuroinflammation
Online-Zugang:	https://www.mdpi.com/1999-4923/14/7/1420
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!